Joint Formulary & PAD

Botulinum toxin type A - Chronic sialorrhoea

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
Associated Icons :
Restrictions / Comments :
Important
ADULTS. NOTE; different brands of botulinum toxin have difference licenses, please check SmPC

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Botulinum toxin type A
Indication :
Chronic sialorrhoea
Group Name :
Keywords :
Brand Names Include :
Xeomin, Botox, Dysport
Important Information :
  • RSFT: Neurology Only
  • SASH: Xeomin only
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Drugs

Below are listed other drugs that are used to treat Chronic sialorrhoea.

  • No records returned.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.